Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MiddleBrook Pharmaceuticals Inc.

Division of Victory Pharma Inc.

Latest From MiddleBrook Pharmaceuticals Inc.

Mylan Breathes Life Into Its Specialty Pharma Unit

In its first investor meeting in four years, Mylan lays out plans to barge over the generics industry’s post-2013 so-called ‘reverse patent cliff’ by focusing on high-barrier-to-entry products – including generic Advair – and portfolio and geographic diversification.

BioPharmaceutical Business Strategies

John Thievon saves the Dey for Mylan

Mylan has appointed John Thievon president of Dey Pharma, its fully integrated specialty pharmaceutical business. Mr Thievon most recently served as president and CEO of MiddleBrook Pharmaceuticals, helping to build the business from an 18-person start-up to a 450-person organisation whose assets were acquired by Victory Pharma.

Shionogi snatches Victory portfolio from jaws of past defeat

Shionogi's US subsidiary has agreed to acquire the entire marketed portfolio of the private US firm Victory Pharma in a move that will bolster its commercial presence in pain and infection.

Cancer Neurology

US Capitol Capsule: US health officials reflect on 30 years of HIV/AIDS

Although the successful progress in detecting and treating HIV/AIDS over the past three decades has been "undeniable," health officials must be clear – "AIDS is not over, not around the world and not here in the US," insisted Dr Jack Whitescarver, director of the Office of AIDS Research (OAR) at the US National Institutes of Health (NIH).  

Immune Disorders Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Advanced Pharma
  • Advancis Pharmaceutical Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Victory Pharma Inc.
  • Senior Management
  • David Becker, EVP, CFO & Acting Pres. & CEO
  • Contact Info
  • MiddleBrook Pharmaceuticals Inc.
    Phone: (817) 837-1200
    7 Village Cir., Ste. 100
    Westlake, TX 76262